Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.400
+0.050 (3.70%)
At close: Nov 17, 2025, 4:00 PM EST
1.360
-0.040 (-2.86%)
After-hours: Nov 17, 2025, 4:54 PM EST

Telomir Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
7.331.2700-
Cash & Short-Term Investments
7.331.2700-
Cash Growth
778.14%102753.86%-13.25%--
Prepaid Expenses
0.070.060--
Other Current Assets
--0.430.05-
Total Current Assets
7.41.320.440.05-
Long-Term Deferred Charges
--4.34--
Total Assets
7.41.324.770.05-
Accounts Payable
0.330.590.710.40.02
Short-Term Debt
0.090.090.630.580.12
Total Current Liabilities
0.420.681.340.990.14
Total Liabilities
0.420.681.340.990.14
Additional Paid-In Capital
45.9331.2417.50.060.06
Retained Earnings
-38.95-30.6-14.06-0.99-0.14
Comprehensive Income & Other
-----0.06
Shareholders' Equity
6.980.643.44-0.94-0.14
Total Liabilities & Equity
7.41.324.770.05-
Total Debt
0.090.090.630.580.12
Net Cash (Debt)
7.241.17-0.63-0.58-0.12
Net Cash Per Share
0.240.04-0.02-0.02-
Filing Date Shares Outstanding
34.3829.7629.6127.1-
Total Common Shares Outstanding
33.8329.7628.6126.83-
Working Capital
6.980.64-0.9-0.94-0.14
Book Value Per Share
0.210.020.12-0.03-
Tangible Book Value
6.980.643.44-0.94-0.14
Tangible Book Value Per Share
0.210.020.12-0.03-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q